MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1/Akt signalling pathway.
Shu YangGuangyan YangHan WuLin KangJiaqing XiangPeilin ZhengShanhu QiuZhen LiangYan LuLijing JiaPublished in: Diabetologia (2021)
Our results identified a previously unrecognised role of miR-193b in muscle function and mass that could be a potential therapeutic target for treating sarcopenia.